Harriman G R, Podack E R, Braude A I, Corbeil L C, Esser A F, Curd J G
J Exp Med. 1982 Oct 1;156(4):1235-49. doi: 10.1084/jem.156.4.1235.
Interaction of the human complement system in normal human serum (NHS) with serum-resistant and -sensitive Neisseria gonorrhoeae was evaluated to better understand the mechanism of serum-resistance. Complement activity (CH50) was depleted from NHS in a dose-dependent fashion by both serum-resistant and -sensitive N. gonorrhoeae. No detectable CH50 remained in NHS incubated with 10(9) colony-forming units (CFU)/ml serum of either resistant or sensitive strains. When smaller numbers of bacteria were incubated with NHS, lesser, yet comparable, amounts of CH50 were depleted by both resistant and sensitive strains. Hemolytic C2 activity was diminished by 33% in the case of resistant N. gonorrhoeae (10(8) CFU/ml serum) and by 48% in the case of a sensitive strain. No detectable decreases in hemolytic C4 or C7 activities were found with either sensitive or resistant strains at this concentration. Both resistant and sensitive strains activated C1s in NHS. Resistant strains specifically activated 19-21% of radiolabeled C1s in NHS, whereas sensitive strains activated 18-32%. Both resistant and sensitive strains also activated C5 in NHS. In binding assays using radiolabeled C5 and C9 in NHS, resistant and sensitive strains bound comparable amounts of C5 and C9. The number of bound C5 and C9 molecules varied according to the number of bacteria or amount of serum used in the assay. The ratio of C9/C5 bound to a sensitive strain was 6.8, and to a resistant strain was 8.2, suggesting that C5 and C9 were incorporated into membrane attack complexes (MAC). Electron microscopic examination of resistant and sensitive strains incubated with NHS revealed that MAC is bound to the surfaces of the resistant strain as well as the sensitive strain.
评估了正常人血清(NHS)中的人类补体系统与血清抗性和血清敏感淋病奈瑟菌的相互作用,以更好地理解血清抗性机制。血清抗性和血清敏感的淋病奈瑟菌均以剂量依赖方式消耗NHS中的补体活性(CH50)。用10⁹菌落形成单位(CFU)/ml抗性或敏感菌株血清孵育的NHS中未检测到CH50残留。当用较少数量的细菌与NHS孵育时,抗性和敏感菌株消耗的CH50量较少但相当。对于抗性淋病奈瑟菌(10⁸CFU/ml血清),溶血C2活性降低33%,对于敏感菌株则降低48%。在此浓度下,敏感或抗性菌株的溶血C4或C7活性均未检测到降低。抗性和敏感菌株均激活NHS中的C1s。抗性菌株特异性激活NHS中19% - 21%的放射性标记C1s,而敏感菌株激活18% - 32%。抗性和敏感菌株也均激活NHS中的C5。在使用NHS中放射性标记的C5和C9的结合试验中,抗性和敏感菌株结合的C5和C9量相当。结合的C5和C9分子数量根据试验中使用的细菌数量或血清量而变化。与敏感菌株结合的C9/C5比率为6.8,与抗性菌株结合的比率为8.2,表明C5和C9被纳入膜攻击复合物(MAC)。对与NHS孵育的抗性和敏感菌株进行电子显微镜检查发现,MAC与抗性菌株以及敏感菌株的表面均有结合。